Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Kazazis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Nephrology|February 9, 2017
Sodium glucose co-transporter 2 inhibitors and their nephroprotective potential
Natalia G Vallianou, Kyriakos Trigkidis, Christos Kazazis
Diabetes & Metabolic Syndrome|June 13, 2017
Diabetic hepatosclerosis: True clinical entity or ghost disease?Natalia G Vallianou, Christos Kazazis, George Ioannidis
Anti-Cancer Agents in Medicinal Chemistry|September 13, 2018
Silimarin and CancerChristina Liakopoulou, Christos Kazazis, Natalia G Vallianou
The Review of Diabetic Studies : RDS|May 21, 2014
Metformin and cancerNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
The Review of Diabetic Studies : RDS|May 21, 2014
Resveratrol and diabetesNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
Anti-Cancer Agents in Medicinal Chemistry|December 4, 2013
Statins and cancerNatalia G Vallianou, Alexandra Kostantinou, Marios Kougias, et al.
Anticancer Research|February 11, 2015
Potential anticancer properties and mechanisms of action of curcuminNatalia G Vallianou, Angelos Evangelopoulos, Nikos Schizas, et al.
Cureus|January 16, 2026
The Regulation of the Holy Hospital Hagios Panteleimon: Administrative and Ethical Framework under the Ottoman HegemonyChristos Kazazis, Ioannis Nikolakakis, Nicholas Tentolouris, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Nephrology|February 9, 2017
Sodium glucose co-transporter 2 inhibitors and their nephroprotective potential
Natalia G Vallianou, Kyriakos Trigkidis, Christos Kazazis
Diabetes & Metabolic Syndrome|June 13, 2017
Diabetic hepatosclerosis: True clinical entity or ghost disease?Natalia G Vallianou, Christos Kazazis, George Ioannidis
Anti-Cancer Agents in Medicinal Chemistry|September 13, 2018
Silimarin and CancerChristina Liakopoulou, Christos Kazazis, Natalia G Vallianou
The Review of Diabetic Studies : RDS|May 21, 2014
Metformin and cancerNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
The Review of Diabetic Studies : RDS|May 21, 2014
Resveratrol and diabetesNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
Anti-Cancer Agents in Medicinal Chemistry|December 4, 2013
Statins and cancerNatalia G Vallianou, Alexandra Kostantinou, Marios Kougias, et al.
Anticancer Research|February 11, 2015
Potential anticancer properties and mechanisms of action of curcuminNatalia G Vallianou, Angelos Evangelopoulos, Nikos Schizas, et al.
Cureus|January 16, 2026
The Regulation of the Holy Hospital Hagios Panteleimon: Administrative and Ethical Framework under the Ottoman HegemonyChristos Kazazis, Ioannis Nikolakakis, Nicholas Tentolouris, et al.
Pageof 1